Table 4 Logistic regression analysis for determining patient characteristics associated with HPV clearance rates during the 6–12-months follow-up

Treatment

FUS

0.644(0.290–1.428)

0.279

1.561(0.487–5.004)

0.454

LEEP

1

1

Age

0.944(0.874–1.021)

0.148

1.032(0.915–1.165)

0.607

Educational background

<University

1.672(0.676–4.135)

0.266

1.318(0.507–3.424)

0.571

≥University

1

1

Contraception

Condom

0.710(0.228–2.210)

0.554

0.840(0.253–2.791)

0.776

Others

2.452(0.421–14.284)

0.319

2.129(0.346–13.086)

0.415

None

1

1

Lifetime sexual partners

1–2

1.175(0.467–2.952)

0.732

0.793(0.295–2.131)

0.646

≥ 3

1

1

Parity

0

0.129(0.016–1.009)

0.051

0.122(0.013–1.162)

0.067

1

0.275(0.034–2.235)

0.227

0.253(0.030–2.134)

0.206

≥ 2

1

1

HPV status

HPV16/18 infection

2.472(0.249–24.561)

0.440

2.170(0.200−23.520)

0.524

Non-HPV16/18 infection

1.347(0.142–12.760)

0.795

1.096(0.105–11.440)

0.939

Negative^*

-

-

-

-

Unknown

1

1